MoneyBloomberg Markets
Samsung Biologics to Raise $2.2 Billion to Fund PolyPeptide Deal
Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.
Join the argument
House rules →Comments load as you scroll.